Is 2019 the Year of the Legal and Compliance Individual?

The Heightened Focus on Individual Liability: New, Special Considerations for Pharmaceutical and Medical Device Companies

June 19, 2019 9:45am

Anne Murray
Orrick, Herrington & Sutcliffe LLP

Jason Jones
King & Spalding

  • Recent enforcement actions against individual executives and key takeaways
  • Scope of legal and compliance professionals’ obligations to monitor suspicious activity and investigate potential red flags
  • What is expected from in-house counsel and compliance executives if your company is under investigation
  • Approaches to compliance and legal roles amid developments in the US and globally, and in response to internal corporate and industry pressures
  • Examination of high risk regions (China, Mexico, Brazil) and the heightened risks confronting local in-house legal and compliance employees